Unexplained infertility means standard fertility tests, semen analysis, ovulation tracking, hormone panels, and tubal assessment all return normal, yet pregnancy hasn’t happened after 12 months of trying (or 6 months if the woman is over 35). It affects 10-30% of infertile couples in India, and most go on to conceive with the right treatment ladder.
Unexplained infertility is a diagnosis of exclusion. Your fertility specialist arrives at it only after every standard investigation has come back normal in both partners, and conception still hasn’t occurred within the expected window. The label can feel dismissive, but it’s clinically precise: it tells you the obvious causes of ovulation, blocked tubes, severe sperm abnormalities, and structural uterine issues have been ruled out. What it does not say is that nothing is wrong. It says current frontline tests cannot detect what is wrong, which is a different problem and a more solvable one.
Standard fertility workups in India check four things reliably: whether the woman ovulates, whether her tubes are open, whether the uterine cavity is anatomically normal, and whether sperm count, motility, and morphology meet WHO thresholds. These tests were designed in an era when those four parameters explained most infertility. They still do, but conception is a multi-step biological cascade involving egg quality at the chromosomal level, sperm DNA integrity, fertilisation competence, embryo development, endometrial receptivity, and immune tolerance. None of these are routinely tested in a basic workup. So when the basic workup is normal, but you’re still not pregnant, the failure is happening at one of these unmeasured steps. The diagnosis isn’t a mystery; it’s a gap in what entry-level testing can see.
Before a fertility specialist commits to the unexplained label, a complete workup should include: semen analysis with strict morphology, mid-luteal progesterone or follicular tracking to confirm ovulation, hysterosalpingography (HSG) or sonosalpingography to confirm both fallopian tubes are open, a transvaginal ultrasound to map the uterus and antral follicle count, AMH and day-2 FSH for ovarian reserve, TSH and prolactin to rule out endocrine drivers, and screening for thyroid autoimmunity where indicated. If everything is normal and you’ve been trying for the relevant duration, the diagnosis stands. If your previous evaluations skipped any of the above, which happens often when workups start in general practice, it’s worth completing the panel before accepting the label.
Treatment for unexplained infertility in India follows a stepwise escalation, calibrated to the woman’s age, ovarian reserve, and how long you’ve already been trying. The first step for younger couples (typically under 35 with good ovarian reserve and short duration of infertility) is timed intercourse with ovulation induction oral medication to stimulate one or two follicles, paired with ultrasound monitoring and a trigger shot to time intercourse. This is usually attempted for three cycles. If unsuccessful, the next step is intrauterine insemination (IUI) with controlled ovarian stimulation, again typically for three cycles. IUI bypasses cervical factors and concentrates motile sperm at the right place at the right time.
If three IUI cycles don’t result in pregnancy, the recommendation shifts to in-vitro fertilisation (IVF). IVF is also the first-line option, skipping ovulation induction and IUI when the woman is over 35, when AMH is low, when infertility duration exceeds three years, or when financial and emotional resources don’t support repeated lower-tier cycles. IVF is diagnostic as well as therapeutic in unexplained cases: it reveals fertilisation rates, embryo development quality, and sometimes uncovers the underlying issue. ICSI is added when fertilisation fails in a previous IVF cycle or when subtle sperm function issues are suspected. PGT-A (preimplantation genetic testing) may be considered when maternal age is advanced or when there’s recurrent implantation failure across cycles.
Even though tests show normal, there are well-recognised subclinical factors that current routine testing misses. Understanding which of these may apply helps shape your treatment choice.
• Egg quality issues at the chromosomal level: Eggs may release on schedule but carry chromosomal errors that prevent viable embryos. Risk rises sharply after 35.
• Sperm DNA fragmentation: Standard semen analysis measures count, motility, and shape, not DNA integrity. High fragmentation can block fertilisation or cause early embryo arrest.
• Endometrial receptivity issues: The uterine lining may appear thick on ultrasound but lack the molecular receptivity required for implantation during the standard window.
• Subclinical endometriosis or adenomyosis: Mild disease that doesn’t cause severe pain or show clearly on ultrasound can still impair fertility through inflammation.
• Tubal function (not just patency): HSG confirms tubes are open but not that the cilia inside transport the egg correctly. Functional tubal failure is invisible to standard imaging.
• Immune and inflammatory factors: Underlying thyroid autoimmunity, undiagnosed coeliac disease, and other inflammatory states are increasingly linked to unexplained subfertility.
• Lifestyle and environmental load: Chronic stress, disturbed sleep, untreated metabolic issues, and exposure to endocrine-disrupting chemicals add cumulative drag on fertility outcomes.
• Confirm your semen analysis was done with strict (Kruger) morphology, not just basic count and motility.
• Check whether tubal patency was assessed by HSG or only inferred from ultrasound; they’re not equivalent.
• Ask whether ovarian reserve was tested with both AMH and antral follicle count.
• Verify thyroid function (TSH and anti-TPO antibodies), and prolactin was checked, not assumed normal.
• If anything in this list was skipped, complete it before moving to treatment. The answer may be there.
• Set a treatment timeline upfront, typically 3 cycles of ovulation induction with timed intercourse or IUI before escalating to IVF, with shorter ladders if maternal age is over 35.
• Discuss with your specialist whether advanced sperm tests (DNA fragmentation index) and endometrial receptivity assessment are warranted before IVF.
• Address modifiable factors in parallel: optimize BMI to within a healthy range, stop smoking and limit alcohol, manage thyroid and metabolic conditions, prioritise sleep and stress management.
• Build emotional support: counseling or peer groups significantly reduce the dropout rate during treatment in Indian patient cohorts.
• Choose a clinic that offers integrated diagnostics and treatment under one team. Fragmented care is one of the biggest reasons unexplained cases stagnate.
Cloudnine Fertility practice(specialist) in Gurgaon offers a structured pre-treatment optimisation programme designed for couples with unexplained infertility, combining advanced diagnostics (sperm DNA fragmentation, endometrial receptivity testing where indicated), individualised lifestyle and metabolic optimization, and a pre-defined treatment ladder so you know exactly when to escalate. Most couples we see arrive after 1-2 unsuccessful cycles elsewhere; a structured workup typically uncovers a treatable factor.
Unexplained infertility benefits more from earlier specialist evaluation than most other diagnoses, because the treatable factors are time-sensitive, especially female age. The thresholds below should trigger a consultation.
If you’ve been told your infertility is unexplained, book a structured consultation with Cloudnine Fertility Clinic for a complete diagnostic audit and a clear treatment plan. The earlier the workup is completed properly, the wider your options stay.
Success rates vary by age, treatment, and clinic. The figures below reflect typical Indian outcome data for couples with unexplained infertility, presented as per-cycle clinical pregnancy rates so you can plan expectations realistically.
Note: Cumulative success across multiple cycles is significantly higher than per-cycle rates. Three IVF cycles in a woman under 35 typically push the cumulative live birth rate above 70%. Per-cycle figures should not be read as outcomes; they are step probabilities along a longer journey.